Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Single-use Technologies for Biopharmaceuticals Market to Reach $16.31 Billion by 2031, Driven by Growing Monoclonal Antibody Production

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as an established player benefiting from scale advantages and regulatory expertise in the growing single-use technologies for biopharmaceuticals market, driven by demand for monoclonal antibodies and cell/gene therapies. MRK Merck KGaA is identified as an established player with scale advantages and regulatory expertise, poised to benefit from the expanding single-use technologies market for biopharmaceuticals, fueled by demand in cancer and diabetes treatments.

Single-use Technologies for Biopharmaceuticals Market to Reach $16.31 Billion by 2031, Driven by Growing Monoclonal Antibody Production Boston, July 31, 2026 (GLOBE NEWSWIRE) -- The global single-use technologies for biopharmaceuticals market is projected to surge from $8.28 billion in 2025 to $16.31 billion by 2031, representing a robust compound annual growth rate (CAGR) of 12.2% during the 2026-2031 forecast period, according to Single-use Technologies for Biopharmaceuticals: Global Markets, a new report from BCC Research.

Key Findings

Market Drivers

The single-use technologies market is experiencing unprecedented growth due to structural shifts in biopharmaceutical manufacturing. The surge in monoclonal antibody production, driven by increasing cancer and diabetes prevalence, is creating massive demand for scalable, contamination-free manufacturing solutions. This trend intersects powerfully with the personalized medicine revolution, where single-use systems provide the flexibility needed for smaller batch sizes and diverse product portfolios.

Simultaneously, the expanding cell and gene therapy sector is driving adoption of single-use technologies due to their inherent advantages in reducing cross-contamination risks and enabling rapid changeovers between products. Government funding for advanced therapies research, combined with rising healthcare expenditures globally, is providing the capital foundation for continued market expansion.

Investment Considerations

The single-use technologies market presents compelling investment opportunities for exposure to the high-growth biopharmaceutical manufacturing sector. Companies offering comprehensive single-use solutions, particularly those with strong automation and sustainability capabilities, are best positioned to capture market share. However, investors should consider regulatory complexity and high capital expenditure requirements that may limit market entry for smaller players. Established players like Sartorius AG, Thermo Fisher Scientific, and Merck KGaA benefit from scale advantages and regulatory expertise, while emerging technologies in process intensification and data-integrated biomanufacturing offer potential upside for early movers.

About the Report

Single-use Technologies for Biopharmaceuticals: Global Markets provides comprehensive market sizing, segmentation analysis, competitive intelligence, and six-year forecasts through 2031.

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.